Literature DB >> 30697698

Medication Appropriateness in Vulnerable Older Adults: Healthy Skepticism of Appropriate Polypharmacy.

Terri R Fried1,2, Marcia C Mecca1,2.   

Abstract

Older adults are prescribed a growing number of medications. Polypharmacy, commonly considered the receipt of five or more medications, is associated with a range of adverse outcomes. There is a debate about the reason(s) why. On one side is the assertion that older persons are being prescribed too many medications, with the number of medications increasing the risk of adverse events. On the other side is the observation that polypharmacy is associated both with overprescribing of inappropriate medications and underprescribing of appropriate medications. This leads to the concept of "inappropriate" vs "appropriate" polypharmacy, with the latter resulting from the prescription of many correct medications to persons with multiple chronic conditions. Few studies have examined the health outcomes associated with adding and/or removing medications to address this debate directly. The criteria used to identify underutilized medications are based on results of randomized controlled trials that may not be generalizable to older adults. Several randomized controlled trials and many more observational studies provide evidence that these criteria overestimate medication benefits and underestimate harms. In addition, evidence suggests that the marginal effects of medications added to an already complex regimen differ from their effects when considered individually. Although in selected circumstances adding medications results in benefit to patients, patients with multimorbidity and frailty/disability have susceptibilities that can decrease the likelihood of medication benefit and increase the likelihood of harms. The identification of appropriate polypharmacy requires more robust criteria to evaluate the net effects of complex medication regimens. Published 2019 This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  medication appropriateness; multimorbidity; polypharmacy

Mesh:

Year:  2019        PMID: 30697698      PMCID: PMC6561813          DOI: 10.1111/jgs.15798

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  30 in total

1.  Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score.

Authors:  Graziano Onder; Mirko Petrovic; Balamurugan Tangiisuran; Marieke C Meinardi; Winih P Markito-Notenboom; Annemie Somers; Chakravarthi Rajkumar; Roberto Bernabei; Tischa J M van der Cammen
Journal:  Arch Intern Med       Date:  2010-07-12

2.  Potential pitfalls of disease-specific guidelines for patients with multiple conditions.

Authors:  Mary E Tinetti; Sidney T Bogardus; Joseph V Agostini
Journal:  N Engl J Med       Date:  2004-12-30       Impact factor: 91.245

3.  The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity.

Authors:  Ryan M Carnahan; Brian C Lund; Paul J Perry; Bruce G Pollock; Kennith R Culp
Journal:  J Clin Pharmacol       Date:  2006-12       Impact factor: 3.126

4.  Polypharmacy and prescribing quality in older people.

Authors:  Michael A Steinman; C Seth Landefeld; Gary E Rosenthal; Daniel Berthenthal; Saunak Sen; Peter J Kaboli
Journal:  J Am Geriatr Soc       Date:  2006-10       Impact factor: 5.562

5.  'Rules of thumb' or reflective practice? Understanding senior physicians' decision-making about anti-thrombotic usage in atrial fibrillation.

Authors:  N Anderson; R Fuller; N Dudley
Journal:  QJM       Date:  2007-03-27

6.  Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.

Authors:  Christoph Wanner; Vera Krane; Winfried März; Manfred Olschewski; Johannes F E Mann; Günther Ruf; Eberhard Ritz
Journal:  N Engl J Med       Date:  2005-07-21       Impact factor: 91.245

7.  Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study.

Authors:  Sheldon Greenfield; John Billimek; Fabio Pellegrini; Monica Franciosi; Giorgia De Berardis; Antonio Nicolucci; Sherrie H Kaplan
Journal:  Ann Intern Med       Date:  2009-12-15       Impact factor: 25.391

8.  Underuse of indicated medications among physically frail older US veterans at the time of hospital discharge: results of a cross-sectional analysis of data from the Geriatric Evaluation and Management Drug Study.

Authors:  Rollin M Wright; Richard Sloane; Carl F Pieper; Christine Ruby-Scelsi; Jack Twersky; Kenneth E Schmader; Joseph T Hanlon
Journal:  Am J Geriatr Pharmacother       Date:  2009-10

Review 9.  Polypharmacy in elderly patients.

Authors:  Emily R Hajjar; Angela C Cafiero; Joseph T Hanlon
Journal:  Am J Geriatr Pharmacother       Date:  2007-12

10.  Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

Authors:  Bengt C Fellström; Alan G Jardine; Roland E Schmieder; Hallvard Holdaas; Kym Bannister; Jaap Beutler; Dong-Wan Chae; Alejandro Chevaile; Stuart M Cobbe; Carola Grönhagen-Riska; José J De Lima; Robert Lins; Gert Mayer; Alan W McMahon; Hans-Henrik Parving; Giuseppe Remuzzi; Ola Samuelsson; Sandor Sonkodi; D Sci; Gultekin Süleymanlar; Dimitrios Tsakiris; Vladimir Tesar; Vasil Todorov; Andrzej Wiecek; Rudolf P Wüthrich; Mattis Gottlow; Eva Johnsson; Faiez Zannad
Journal:  N Engl J Med       Date:  2009-03-30       Impact factor: 91.245

View more
  6 in total

1.  Longitudinal Investigation of Older Adults' Ability to Self-Manage Complex Drug Regimens.

Authors:  Stacy Cooper Bailey; Lauren A Opsasnick; Laura M Curtis; Alex D Federman; Julia Y Benavente; Rachel O'Conor; Michael S Wolf
Journal:  J Am Geriatr Soc       Date:  2019-11-25       Impact factor: 5.562

2.  Effect of Clinical Geriatric Assessments and Collaborative Medication Reviews by Geriatrician and Family Physician for Improving Health-Related Quality of Life in Home-Dwelling Older Patients Receiving Polypharmacy: A Cluster Randomized Clinical Trial.

Authors:  Rita Romskaug; Eva Skovlund; Jørund Straand; Espen Molden; Hege Kersten; Kaisu H Pitkala; Christofer Lundqvist; Torgeir B Wyller
Journal:  JAMA Intern Med       Date:  2020-02-01       Impact factor: 21.873

Review 3.  N-of-1 trials to facilitate evidence-based deprescribing: Rationale and case study.

Authors:  Parag Goyal; Monika M Safford; Sarah N Hilmer; Michael A Steinman; Daniel D Matlock; Mathew S Maurer; Mark S Lachs; Ian M Kronish
Journal:  Br J Clin Pharmacol       Date:  2022-07-13       Impact factor: 3.716

4.  Polypharmacy trajectories among older women with and without dementia: A longitudinal cohort study.

Authors:  Kailash Thapaliya; Melissa L Harris; Julie E Byles
Journal:  Explor Res Clin Soc Pharm       Date:  2021-08-05

5.  Assessment of the appropriateness of cardiovascular preventive medication in older people: using the RAND/UCLA Appropriateness Method.

Authors:  Milly A van der Ploeg; Rosalinde K E Poortvliet; Wilco P Achterberg; Simon P Mooijaart; Jacobijn Gussekloo; Yvonne M Drewes
Journal:  BMC Geriatr       Date:  2022-05-05       Impact factor: 4.070

6.  "At 80 I Know Myself": Embodied Learning and Older Adults' Experiences of Polypharmacy and Perceptions of Deprescribing.

Authors:  Alison Ross; James Gillett
Journal:  Gerontol Geriatr Med       Date:  2019-12-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.